217 related articles for article (PubMed ID: 24769519)
1. Recurrent pseudocellulitis due to gemcitabine: underrecognized and underreported?
Dasanu CA; Bockorny B
J Oncol Pharm Pract; 2015 Oct; 21(5):377-9. PubMed ID: 24769519
[TBL] [Abstract][Full Text] [Related]
2. A rash diagnosis: Gemcitabine-associated pseudocellulitis.
Strouse C; Epperla N
J Oncol Pharm Pract; 2017 Mar; 23(2):157-160. PubMed ID: 26946530
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine associated pseudocellulitis.
Singh A; Hampole H
J Gen Intern Med; 2012 Dec; 27(12):1721. PubMed ID: 22696254
[No Abstract] [Full Text] [Related]
4. Gemcitabine associated pseudocellulitis: A missed diagnosis.
Gill D; Schrader J; Kelly M; Martinez F; Syed W; Wright J
J Oncol Pharm Pract; 2018 Oct; 24(7):550-552. PubMed ID: 28714381
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine-induced pseudocellulitis: a case report and review of the literature.
Bami H; Goodman C; Boldt G; Vincent M
Curr Oncol; 2019 Oct; 26(5):e703-e706. PubMed ID: 31708665
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema: A Case Report and Review of the Current Literature.
Curtis S; Hong S; Gucalp R; Calvo M
Am J Ther; 2016; 23(1):e321-3. PubMed ID: 24451298
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine-associated "pseudocellulitis" and "pseudosepsis": a case report and review of the literature.
Obeid KM; Venugopal AA
Am J Ther; 2013 Jan; 20(1):118-20. PubMed ID: 21768869
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine-related "pseudocellulitis": report of 2 cases and review of the literature.
Tan DH; Bunce PE; Liles WC; Gold WL
Clin Infect Dis; 2007 Sep; 45(5):e72-6. PubMed ID: 17682983
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine-induced pseudocellulitis.
Caplan A; Chu DH; Rosenbach M; Svoboda J
Cutis; 2018 Nov; 102(5):E20-E23. PubMed ID: 30566560
[No Abstract] [Full Text] [Related]
10. Recurrent cutaneous toxic erythema induced by gemcitabine in a patient with pancreatic cancer.
Li J; Ko CJ; Saif MW
Cutan Ocul Toxicol; 2009; 28(3):144-8. PubMed ID: 19527102
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-Induced Pseudocellulitis Without Prior Radiation Exposure: A Systematic Review.
Kovacs LD; O'Donoghue M; Cogen AL
JAMA Dermatol; 2023 Aug; 159(8):870-874. PubMed ID: 37379014
[TBL] [Abstract][Full Text] [Related]
12. Recurrent lower extremity pseudocellulitis.
Korniyenko A; Lozada J; Ranade A; Sandhu G
Am J Ther; 2012 Jul; 19(4):e141-2. PubMed ID: 22772033
[TBL] [Abstract][Full Text] [Related]
13. A case of gemcitabine-related acute lipodermatosclerosis.
Nyckowski T; McGregor S; Huang WW
J Oncol Pharm Pract; 2019 Jul; 25(5):1271-1274. PubMed ID: 30041585
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine-induced hepatitis in a pancreatic cancer patient receiving adjuvant therapy following metastasectomy.
Saadati H; Peccerillo J; Kaley K; Schilsky ML; Saif MW
JOP; 2009 Sep; 10(5):573-5. PubMed ID: 19734642
[No Abstract] [Full Text] [Related]
15. Do recurrent and metastatic pancreatic cancer patients have the same outcomes with gemcitabine treatment?
Hashimoto K; Ueno H; Ikeda M; Kojima Y; Hagihara A; Kondo S; Morizane C; Okusaka T
Oncology; 2009; 77(3-4):217-23. PubMed ID: 19729980
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine and haemolytic-uraemic syndrome.
Ruiz I; Del Valle J; Gómez A
Ann Oncol; 2004 Oct; 15(10):1575-6. PubMed ID: 15367421
[No Abstract] [Full Text] [Related]
17. Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.
Pentsova E; Liu A; Rosenblum M; O'Reilly E; Chen X; Hormigo A
J Neurooncol; 2012 Jan; 106(1):15-21. PubMed ID: 21811892
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of gemcitabine therapy for recurrent or metastatic pancreatic cancer].
Moriwaki T; Hyodo I; Nishina T; Nasu J; Hidaka S; Kajiwara T; Tsuzuki T; Hirao K; Tsubouchi E; Yamauchi Y; Hirasaki S; Masumoto T; Tanada M
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1373-6. PubMed ID: 15446559
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine doublets in advanced pancreatic cancer: should we move on?
Rocha Lima CM; Flores AM
J Clin Oncol; 2006 Jan; 24(3):327-9. PubMed ID: 16344312
[No Abstract] [Full Text] [Related]
20. Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma.
Ling W; Sachdeva P; Wong AS; Lee SC; Zee YK
Pancreas; 2012 May; 41(4):659-61. PubMed ID: 22504387
[No Abstract] [Full Text] [Related]
[Next] [New Search]
